Peixin Xu

CIK 1705781 · President · last filed 2023-05-31

Peixin Xu is a President who has filed 10 SEC Form 4 insider transactions across 4 companies since 2017. The most recent filing, for CNVS, was dated May 31, 2023. Across all open-market trades the lifetime net is +$14.41T, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $2.8M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$2.84M

Companies

4

Total Filings

10

Lifetime Open-Market Net

$14414.99B

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
CNVS	Director	1,005,607	$2.82	$2.84M	-$612.0K	1	2023-05-31
Cineverse Corp. (CIDM) Delisted	Director	20,397,721	$0.29	$6.01M	$14414.99B	7	2021-08-26
XYNOMIC PHARMACEUTICALS HOLDINGS, INC. (XYNPW) Delisted		1,628,580	—	—	$0	1	2019-05-21
XYNOMIC PHARMACEUTICALS HOLDINGS, INC. (BCACU) Delisted	President	1,519,600	$23.20	$35.25M	$0	1	2017-06-28

Recent Filings

10 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2023-05-31	CNVS	Mixed	−1,069,828	-$612.0K	EDGAR
2021-08-26	Cineverse Corp. (CIDM) Delisted	Sell (S)	−10,566,667	$0	EDGAR
2021-01-13	Cineverse Corp. (CIDM) Delisted	Sell (S)	−13,017,660	-$8.14M	EDGAR
2020-05-20	Cineverse Corp. (CIDM) Delisted	Buy (P)	+29,855,081	$0	EDGAR
2019-11-21	Cineverse Corp. (CIDM) Delisted	Buy (P)	+3,900,000	$14415.00B	EDGAR
2019-05-21	XYNOMIC PHARMACEUTICALS HOLDINGS, INC. (XYNPW) Delisted	Buy (P)	+108,980	$0	EDGAR
2018-12-19	Cineverse Corp. (CIDM) Delisted	Grant (A)	+43,103	$0	EDGAR
2018-01-30	Cineverse Corp. (CIDM) Delisted	Grant (A)	+31,609	$0	EDGAR
2018-01-02	Cineverse Corp. (CIDM) Delisted	Other (J)	—	$0	EDGAR
2017-06-28	XYNOMIC PHARMACEUTICALS HOLDINGS, INC. (BCACU) Delisted	Buy (P)	+39,375	$0	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.